Large Store Chain In Japan To Sell OTC Drugs Under Changed Rule
This article was originally published in PharmAsia News
FamilyMart, a nationwide retail chain in Japan, plans to sell over-the-counter drugs at as many as 150 of its stores by 2011. Beginning next April, a new regulation takes effect allowing retailers to sell OTC drugs that do not have a high risk of side effects. The rule requires a registered salesperson to be present in the store. FamilyMart, a chain of 7,000 convenience stores, is the first major retailer to announce it would take advantage of the rule relaxation. (Click here for more - a subscription may be required
You may also be interested in...
Office of New Drugs Director Peter Stein said in an interview that a large amount of coronavirus-related work is arriving at the FDA, but so far staff are keeping up.
Akero’s FGF21 analog yields 63%-72% relative hepatic fat reduction in Phase IIa study; the company awaits biopsy data hoping to see a fibrotic benefit. Also, Genfit says COVID-19 pandemic should not significantly delay its Phase III NASH readout.
US Vice President Mike Pence and Medicare administrator Seema Verma want academic and university hospital laboratories to send their de-identified COVID-19 test data results, daily, to the Department of Health and Human Services. Commercial and private labs are exempt from the request, as they already share their coronavirus test results with the government.